Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Daniel is a founding executive team member of Pipeline Therapeutics where he currently serves as Chief Scientific Officer. Previously, he was VP of Biology at Inception Sciences — a Versant Ventures discovery engine — where he led all aspects of biology and non-clinical pharmacology, including the acquisition of the remyelination company Inception
5 by Roche pharmaceuticals. Prior to joining Inception, Dan was Senior Director of Pharmacology at Amira Pharmaceuticals and contributed to the discovery of several clinical stage small molecule therapeutics to treat inflammation and fibrosis. Notably, he led the efforts of the LPA1R program that was acquired by BMS. Prior to that, he was a Research Fellow at Merck where he contributed to early CNS drug discovery. He was a postdoctoral fellow at the University of Chicago and received a PhD in Behavioral Neuroscience from the University of Buffalo.
